Praxis Precision Medicines Inc (NASDAQ:PRAX) currently has a daily average trading volume of 417.76K but it saw 254696 shares traded in last market. With a market cap of 875.26M USD, the company’s current market price of $42.97 came falling about -1.13 while comparing to the previous closing price of $43.46. In past 52 weeks, the stock remained buoying in the range of price level as high as $91.83 and as low as $26.70. In the recent trading on the day, stock has struck highest price mark of $42.61 while lowest mark touched by it was $44.985.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Oppenheimer which resumed the stock as “Outperform” in its note to investors issued on June 02, 2025, recommending a price target of $97 for it. H.C. Wainwright issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $120 and $105.
Over the week, PRAX’s stock price is moving -3.64% down while it is 15.05% when we observe its performance for the past one month. Year-to-date it is -44.17% down and over the past year, the stock is showing an upside performance of 10.26%.
The company is expected to be releasing its next quarterly report on 2025-May-02, for which analysts forecasted an EPS of -3.3 while estimate for next year EPS is -13.0. In next quarter, company is expected to be making quarterly sales of $152.68k as analysts are expecting the sales for current fiscal year at $691.92k and seeing the company making $20.92M in sales next year. Moreover, analysts are in estimates of $157.13k for current-quarter revenue.
Currently, Praxis Precision Medicines Inc’s total number of outstanding shares is 20.34M. Company’s return on investment (ROI) stands at -48.40% and return on equity (ROE) at -63.56%. Stock’s beta reads 2.62. Stock has a price to book (P/B) ratio of 1.99 while price to sale or P/S ratio amounts to 107.79. Its return on asset (ROA) is -58.30% on average.
